Wed, Apr 16, 2014, 8:54 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • trendsearcher trendsearcher Jun 27, 2012 8:03 PM Flag

    Gregg is Scared

    "It's always easier to get a non invasive system approved, compared with an invasive one."

    Invasiveness really is not the main question for a BGM system. The main questions are accuracy and precision. With diabetes if you give the wrong answer there can be some very serious consequences. I think the approval process would not be much deferent between transcutaneous vs subcutaneous. The testing sure; but the actual agency reviews should be similar. And don’t forget the problems Cygnus had with their transcutaneous device. Just because it doesn’t break the skin does not always mean a device is non-invasive.

    Where a less invasive product would shine is with market acceptance.

    As far a Gregg’s reference to the competition, I’ve listened to his investor presentations for years when he was with MiniMed and DexCom. As far as I can remember a time when he has always had some discussion about the competitive space. I would read too much into the presence or absence of the competitive space details.

 
DXCM
36.03+1.87(+5.47%)Apr 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Google Inc.
NasdaqGSWed, Apr 16, 2014 4:00 PM EDT
Google Inc.
NasdaqGSWed, Apr 16, 2014 4:00 PM EDT